Showing 11353–11364 of 31213 results

Calcitrate tablets, 100

33.04
To prevent calcium deficiency in case of increased demand (e.g. growth, age, pregnancy, lactation). For supportive treatment of osteoporosis.

Calcimed D3 500 mg / 1000 IU chewable tablets, 48

41.71
For the prophylaxis and treatment of Calcium and Vitamin D deficiency in the elderly and as a Calcium - and Vitamin D Supplement for supportive treatment of osteoporosis

Calcimed D3 500 mg / 1000 IU chewable tablets, 120

63.83
For the prophylaxis and treatment of Calcium and Vitamin D deficiency in the elderly and as a Calcium - and Vitamin D Supplement for supportive treatment of osteoporosis

Calcimed D3 1000 mg / 880 IU chewable tablets, 96

65.74
For the prophylaxis and treatment of Calcium and Vitamin D deficiency in the elderly.

Calcimed D3 1000 mg / 880 IU chewable tablets, 48

39.09
For the prophylaxis and treatment of Calcium and Vitamin D deficiency in the elderly.

Calcimed 500 mg effervescent tablets, 20

19.91
For the treatment of a calcium deficiency and for osteoporosis treatment.

Calcimagon D3, 112

58.08
As vitamin D and calcium supplement to support a specific therapy and for the prevention and treatment of osteoporosis.

Calcilac mono 500 mg chewable tablets, 40

21.47
For the prevention and treatment of calcium deficiency and as an adjunct to specific osteoporosis therapy.

Calcilac mono 500 mg chewable tablets, 100

36.03
For the prevention and treatment of calcium deficiency and as an adjunct to specific osteoporosis therapy.

CALCILAC effervescent tablets, 40

35.32
To compensate for a simultaneous calcium and vitamin D deficiency.

Calcilac chewable tablets, 50

30.43
For the prevention and treatment of Calcium and Vitamin D deficiency in the elderly and as a supplement to support a specific osteoporosis therapy for patients in whom the risk of Vitamin-D and calcium deficiency exists.

Calcilac chewable tablets, 180

48.69
For the prevention and treatment of Calcium and Vitamin D deficiency in the elderly and as a supplement to support a specific osteoporosis therapy for patients in whom the risk of Vitamin-D and calcium deficiency exists.